The Regulatory Reality of 2026: What Actually Changed In late 2023, the FDA moved 19 peptides, including BPC-157, to what's known as "Category 2" status under its framework for bulk drug substances used in compounding, identifying them as substances that "may present significant safety risks." The concern, as stated in FDA guidance, centered on the limited large-scale human data and questions about immunogenicity
This stuff is amazing I love it I have had nothing but great service and success with this company including product, delivery and customer service
Space morning and evening doses approximately 12 hours apart
Each bottle lasts 2 months and, at this price, compared mg per mg to competing products, you might regret buying less concentrated products
If you're using a strong retinoid or exfoliant, it's best to be cautious, as layering too many actives may cause irritation